We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+10.21%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$269M
AUM Growth
+$62.5M
Cap. Flow
-$58.3M
Cap. Flow %
-21.7%
Top 10 Hldgs %
34.36%
Holding
139
New
24
Increased
37
Reduced
15
Closed
24

Top Buys

Rank Stock Value
1
PLAB icon
Photronics
PLAB
+$4.08M
2
PDFS icon
PDF Solutions
PDFS
+$3.72M
3
CYBE
Cyberoptics Corp
CYBE
+$3.23M
4
XFOR icon
X4 Pharmaceuticals
XFOR
+$2.8M
5
PDSB icon
PDS Biotechnology
PDSB
+$2.72M

Top Sells

Rank Stock Value
1
COHU icon
Cohu
COHU
+$6.92M
2
TLND
Talend S.A. American Depositary Shares
TLND
+$4.19M
3
RMNI icon
Rimini Street
RMNI
+$2.49M
4
NVVE
Nuvve Holding Corp
NVVE
+$1.93M
5
SBBP
Strongbridge Biopharma plc.
SBBP
+$1.52M

Sector Composition

Rank Sector Weight
1 Technology 18.01%
2 Healthcare 12.43%
3 Industrials 3.3%
4 Consumer Discretionary 3.05%
5 Financials 2.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HTGM
51
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$832K 0.31%
11,928
+7,366
+161% +$399K
ARDS
52
DELISTED
Aridis Pharmaceuticals Inc. Common Stock
ARDS
$780K 0.29%
105,413
– –
ATEN icon
53
A10 Networks
ATEN
$2.16B
$767K 0.29%
68,130
+2,748
+4% +$26.6K
PCSA icon
54
Processa Pharmaceuticals
PCSA
$5.65M
$745K 0.28%
182
– –
PGR icon
55
Progressive
PGR
$124B
$717K 0.27%
7,298
+3,752
+106% +$371K
YTEN
56
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$680K 0.25%
3,320
-401
-11% -$89.3K
FARO
57
DELISTED
Faro Technologies
FARO
$679K 0.25%
8,727
-400
-4% -$31.5K
DAIO icon
58
Data I/O
DAIO
$30M
$676K 0.25%
99,266
+9,303
+10% +$55.3K
MDNA
59
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$647K 0.24%
215,030
+17,130
+9% +$63.4K
TAOX
60
Tao Synergies Inc
TAOX
$25.3M
$642K 0.24%
+2,956
New +$693K
OEF icon
61
PUT
iShares S&P 100 ETF
OEF
$19.9B
$577K 0.21%
175,300
+10,400
+6% +$1.98M
NVNO
62
enVVeno Medical
NVNO
$7.1M
$569K 0.21%
2,368
-510
-18% -$109K
EVOK
63
DELISTED
Evoke Pharma
EVOK
$545K 0.2%
2,762
+425
+18% +$91K
CYTHW
64
DELISTED
Cyclo Therapeutics, Inc. Warrant
CYTHW
$458K 0.17%
88,690
– –
DCOY
65
Decoy Therapeutics
DCOY
$2.09M
$450K 0.17%
12
– –
IPWR icon
66
Ideal Power
IPWR
$60.9M
$427K 0.16%
+33,572
New +$364K
NVEC icon
67
NVE Corp
NVEC
$555M
$403K 0.15%
+5,448
New +$388K
CTO
68
CTO Realty Growth
CTO
$820M
$345K 0.13%
19,365
+1,200
+7% +$21.2K
MTN icon
69
Vail Resorts
MTN
$5.45B
$330K 0.12%
+1,042
New +$332K
HSDT icon
70
Solana Company
HSDT
$99.3M
– –
-1
Closed -$594K
EXPE icon
71
Expedia Group
EXPE
$35.2B
$286K 0.11%
+1,745
New +$299K
UHAL icon
72
U-Haul Holding Co
UHAL
$13.9B
$242K 0.09%
+4,100
New +$240K
EQC
73
DELISTED
Equity Commonwealth
EQC
$242K 0.09%
9,253
+400
+5% +$11.1K
CXP
74
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
$241K 0.09%
13,847
+2,000
+17% +$36K
CIO
75
DELISTED
City Office REIT
CIO
$233K 0.09%
18,750
-6,150
-25% -$71.2K
1 2
3
4 5

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
WTG
West Tower Group Richmond, Virginia $32.1M AUM 33.19% 1-Year Est. Return
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
LGM
Lykos Global Management Stamford, Connecticut $30.4M AUM

Worth Venture Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Worth Venture Partners held 139 positions worth $269M, up 30% from $206M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Worth Venture Partners withdrew a net $58.3M in Q2 2021, closing 24 positions and reducing 15 holdings. Its most notable exit was Cohu, an estimated $6.92M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 21% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Worth Venture Partners opened a new position in Photronics worth $4.12M.

  • Worth Venture Partners's largest Q2 2021 buy was Photronics: 311,669 shares worth $4.12M.
  • Worth Venture Partners added most to Galera Therapeutics, Inc. Common Stock in Q2 2021, an estimated $2.07M increase.
  • Worth Venture Partners's biggest Q2 2021 reduction was Allot, cutting an estimated $346K.
  • Worth Venture Partners fully exited Cohu in Q2 2021, selling an estimated $6.92M.
  • Worth Venture Partners's ten largest holdings make up 34% of its $269M portfolio in Q2 2021.
  • Worth Venture Partners opened 24 new positions and closed 24 in Q2 2021.
  • Worth Venture Partners's portfolio value rose 30% quarter-over-quarter to $269M.

Based on Worth Venture Partners's 13F filing for Q2 2021, filed 16 Aug 2021.